Related Experiment Videos

Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma

F Calabresi¹, M Aapro, D Becquart

¹Istituto Regina Elena, Roma, Italy.

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|May 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50.

ESMO open·2025

Nefopam Misuse: A Cross-Sectional Study in France.

European journal of pain (London, England)·2025

A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).

ESMO open·2025

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO).

ESMO open·2024

Identification of the first homozygous intragenic deletion in the YY1AP1 gene in a consanguineous family: New insights into the phenotypic variability associated with Grange syndrome.

American journal of medical genetics. Part A·2023

See all related articles